Bookmarks
UK BioLAM
Population Size
300
People
Years
2004
Associated BioSamples
Other
Geographic coverage
United Kingdom
England
Lead time
Not applicable
Summary
Lymphangioleiomyomatosis (LAM) is a multi-system disease of women. Metabolomics have been used to determine if metabolites downstream of mTOR and other LAM realted pathways were present or related to disease progression in a national cohort.
Documentation
Lymphangioleiomyomatosis (LAM) is a rare lung and lymphatic disease categorised by infiltration of smooth muscle type cells in the lungs and lymphatics leading to progressive respiratory impairment. The disease only effects women and is caused by a defect in one of the two proteins associated with tuberous sclerosis, tuberin and hamartin.
Dataset type
Health and disease
Dataset sub-type
Not applicable
Dataset population size
300
Keywords
Observations
Observed Node | Disambiguating Description | Measured Value | Measured Property | Observation Date |
|---|---|---|---|---|
Persons | 300 | Count | 01 Oct 2004 |
Provenance
Purpose of dataset collection
Study
Source of data extraction
Paper-based
Collection source setting
Secondary care - In-patients
Image contrast
Not stated
Biological sample availability
Other
Structural Metadata
Details
Publishing frequency
Irregular
Version
1.0.0
Modified
08/10/2024
Coverage
Start date
01/10/2004
Time lag
Variable
Geographic coverage
United Kingdom, England
Minimum age range
18
Maximum age range
65
Follow-up
Unknown
Accessibility
Language
en
Controlled vocabulary
LOCAL
Format
csv
Data Access Request
Dataset pipeline status
Not available
Access rights
In Progress
Time to dataset access
Not applicable
Jurisdiction
GB-ENG
Data Controller
Professor Simon Johnson